Relevant bibliographies by topics / ARDS, PET imaging, CT imaging, inflammation

Academic literature on the topic 'ARDS, PET imaging, CT imaging, inflammation'

Author: Grafiati
Published: 9 March 2023
Last updated: 10 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'ARDS, PET imaging, CT imaging, inflammation.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "ARDS, PET imaging, CT imaging, inflammation"

1

Wells, R. Glenn, and Terrence D. Ruddy. "The dream of imaging coronary artery inflammation with FDG PET/CT imaging." Journal of Nuclear Cardiology 24, no. 4 (June 3, 2016): 1171–74. http://dx.doi.org/10.1007/s12350-016-0549-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Emami, Hamed, and Ahmed Tawakol. "Noninvasive imaging of arterial inflammation using FDG-PET/CT." Current Opinion in Lipidology 25, no. 6 (December 2014): 431–37. http://dx.doi.org/10.1097/mol.0000000000000135.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Saraste, Antti, and Juhani Knuuti. "Optimizing FDG-PET/CT imaging of inflammation in atherosclerosis." Journal of Nuclear Cardiology 22, no. 3 (March 31, 2015): 480–82. http://dx.doi.org/10.1007/s12350-015-0112-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Vorster, Mariza, John Buscombe, Ziauddin Saad, and Mike Sathekge. "Past and Future of Ga-citrate for Infection and Inflammation Imaging." Current Pharmaceutical Design 24, no. 7 (May 14, 2018): 787–94. http://dx.doi.org/10.2174/1381612824666171129200611.

Full text
Abstract:
Both 67Ga and 68Ga-citrates are used to detect a wide spectrum of pathology consisting of various inflammatory, infectious and malignant conditions. Considering the now widespread availability and constantly increasing demand for PET/CT studies,68Ga-citrate is gaining ground in clinical settings and the added value of combined metabolic and anatomical imaging achieved by combining PET with Computed Tomography (CT) to PET/CT makes 68Ga-citrate particularly promising. Despite the tracer's non-specificity, it has demonstrated potential especially in the evaluation of various infectious and inflammatory skeletal- and lung conditions. In this review, we will focus on the indications and lessons learned from 67Ga, and present the current status for the use of 68Ga-citrate PET/CT in selected inflammation and infectious diseases based on the limited literature available.
APA, Harvard, Vancouver, ISO, and other styles
5

Keidar, Zohar. "FDG PET/CT Imaging in Diabetic Patients - A Special Emphasis on Imaging of Infection." Current Pharmaceutical Design 24, no. 7 (May 14, 2018): 806–13. http://dx.doi.org/10.2174/1381612824666171129202647.

Full text
Abstract:
Nuclear Medicine (NM) imaging plays a major role in the assessment of infection and inflammation. Tracers, including single photon emitting radionuclides for Single Photon Emission Tomography (SPECT) and agents for positron emission tomography (PET), reflect primarily tissue and cellular function or metabolism. In the specific clinical setting of a patient with suspected infectious or inflammatory process, planar scintigraphy, SPECT or PET procedures are used to support a clinically suspected diagnosis. Integrating metabolic and anatomic information using a single SPECT/CT or PET/CT technique has substantially improved the diagnostic accuracy of these imaging tests and advanced the NM technology to be a significant and important tool in the field of infection and inflammation. Diabetes, one of the most prevalent diseases, has a direct relationship with the development of various infection related condition. Due to alterations in different metabolic pathways, imaging of the diabetic patient may be subject to specific pitfalls and obstacles which should be taken into consideration. This review aimed at describing the impact of diabetes and hyperglycemia on NM imaging, with an emphasis on FDGPET/ CT, in specific infectious conditions related to diabetes.
APA, Harvard, Vancouver, ISO, and other styles
6

Lawal, Ismaheel O., Gbenga O. Popoola, Johncy Mahapane, Jens Kaufmann, Cindy Davis, Honest Ndlovu, Letjie C. Maserumule, et al. "[68Ga]Ga-Pentixafor for PET Imaging of Vascular Expression of CXCR-4 as a Marker of Arterial Inflammation in HIV-Infected Patients: A Comparison with 18F[FDG] PET Imaging." Biomolecules 10, no. 12 (December 3, 2020): 1629. http://dx.doi.org/10.3390/biom10121629.

Full text
Abstract:
People living with human immunodeficiency virus (PLHIV) have excess risk of atherosclerotic cardiovascular disease (ASCVD). Arterial inflammation is the hallmark of atherogenesis and its complications. In this study we aimed to perform a head-to-head comparison of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography ([18F]FDG PET/CT) and Gallium-68 pentixafor positron emission tomography/computed tomography [68Ga]Ga-pentixafor PET/CT for quantification of arterial inflammation in PLHIV. We prospectively recruited human immunodeficiency virus (HIV)-infected patients to undergo [18F]FDG PET/CT and [68Ga]Ga-pentixafor PET/CT within two weeks of each other. We quantified the levels of arterial tracer uptake on both scans using maximum standardized uptake value (SUVmax) and target–background ratio. We used Bland and Altman plots to measure the level of agreement between tracer quantification parameters obtained on both scans. A total of 12 patients were included with a mean age of 44.67 ± 7.62 years. The mean duration of HIV infection and mean CD+ T-cell count of the study population were 71.08 ± 37 months and 522.17 ± 260.33 cells/µL, respectively. We found a high level of agreement in the quantification variables obtained using [18F]FDG PET and [68Ga]Ga-pentixafor PET. There is a good level of agreement in the arterial tracer quantification variables obtained using [18F]FDG PET/CT and [68Ga]Ga-pentixafor PET/CT in PLHIV. This suggests that [68Ga]Ga-pentixafor may be applied in the place of [18F]FDG PET/CT for the quantification of arterial inflammation.
APA, Harvard, Vancouver, ISO, and other styles
7

Alie, Nadia, Mootaz Eldib, Zahi A. Fayad, and Venkatesh Mani. "Inflammation, Atherosclerosis, and Coronary Artery Disease: PET/CT for the Evaluation of Atherosclerosis and Inflammation." Clinical Medicine Insights: Cardiology 8s3 (January 2014): CMC.S17063. http://dx.doi.org/10.4137/cmc.s17063.

Full text
Abstract:
Atherosclerosis is a prevalent cardiovascular disease marked by inflammation and the formation of plaque within arterial walls. As the disease progresses, there is an increased risk of major cardiovascular events. Owing to the nature of atherosclerosis, it is imperative to develop methods to further understand the physiological implications and progression of the disease. The combination of positron emission tomography (PET)/computed tomography (CT) has proven to be promising for the evaluation of atherosclerotic plaques and inflammation within the vessel walls. The utilization of the radiopharmaceutical tracer, 18F-fluorodeoxyglucose (18F-FDG), with PET/CT is invaluable in understanding the pathophysiological state involved in atherosclerosis. In this review, we will discuss the use of 18F-FDG-PET/CT imaging for the evaluation of atherosclerosis and inflammation both in preclinical and clinical studies. The potential of more specific novel tracers will be discussed. Finally, we will touch on the potential benefits of using the newly introduced combined PET/magnetic resonance imaging (MRI) for non-invasive imaging of atherosclerosis.
APA, Harvard, Vancouver, ISO, and other styles
8

Malviya, Gaurav, Erik F. J. de Vries, Rudi A. Dierckx, and Alberto Signore. "Radiopharmaceuticals for imaging chronic lymphocytic inflammation." Brazilian Archives of Biology and Technology 50, spe (September 2007): 1–13. http://dx.doi.org/10.1590/s1516-89132007000600002.

Full text
Abstract:
In the last few decades, a number of radiopharmaceuticals for imaging inflammation have been proposed that differ in their specificity and mechanism of uptake in inflamed foci as compared to the traditional inflammation imaging agents. Radiolabelled cytokines represent a reliable tool for the preclinical diagnosis of chronic inflammatory processes, even before anatomical and functional changes occur in affected tissues. Moreover, the introduction of radiolabelled monoclonal antibodies and sophisticated technique like PET/CT now make the field of inflammation imaging highly specific and accurate. In this review, different approaches of the established and experimental radiopharmaceuticals for imaging of chronic inflammation are discussed.
APA, Harvard, Vancouver, ISO, and other styles
9

Menezes, L. J., C. W. Kotze, B. F. Hutton, R. Endozo, J. C. Dickson, I. Cullum, S. W. Yusuf, P. J. Ell, and A. M. Groves. "Vascular Inflammation Imaging with 18F-FDG PET/CT: When to Image?" Journal of Nuclear Medicine 50, no. 6 (May 14, 2009): 854–57. http://dx.doi.org/10.2967/jnumed.108.061432.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Arnon-Sheleg, Elite, Ora Israel, and Zohar Keidar. "PET/CT Imaging in Soft Tissue Infection and Inflammation—An Update." Seminars in Nuclear Medicine 50, no. 1 (January 2020): 35–49. http://dx.doi.org/10.1053/j.semnuclmed.2019.07.005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "ARDS, PET imaging, CT imaging, inflammation"

1

ZAMBELLI, VANESSA. "Pet imaging for evaluation of inflammatory response in a murine model of acute respiratory failure." Doctoral thesis, Università degli Studi di Milano-Bicocca, 2013. http://hdl.handle.net/10281/43295.

Full text
Abstract:
Background: Acute Respiratory Distress Syndrome (ARDS) is a life-threatening form of acute respiratory failure, with a still high mortality. Aspiration pneumonitis is a clinical disorder that, entailing a direct lung injury, is associated to ARDS. It is characterized by an acute inflammatory response with neutrophilic recruitment into the lung and a late fibrotic evolution of injury. This study investigates whether the use of PET could allow to monitor this inflammatory response and its correlation with the later fibroproliferative phase in an experimental model of acute respiratory failure. Since to date no specific therapeutic strategies are available for ARDS patients, we tested the effects of exogenous surfactant treatment on lung injury evolution, by monitoring it with CT-PET imaging. Methods: Hydrochloric acid (0,1M) was instilled (1,5 ml/kg) into the right bronchus of mice. The study was divided into three parts. Time-course experiment: four groups of mice underwent micro-CT and micro-PET scans and sacrificed at different time point (6hrs, 24 hrs, 48 hrs and 7 days after surgery) to assess arterial blood gases, histology and bronchoalveolar lavage (BAL). Long-term experiment: one group of mice underwent a micro-CT scan 1 hour after lung injury and a series of [18F]FDG-PET at the same time points. 21 days after respiratory static compliance was measured and lung tissue was collected in order to measure the OH-proline content. Treatment experiment: two groups of mice were treated with exogenous surfactant (Curosurf ®) or vehicle (sterile saline 0.9 %) three hours after HCl instillation. Animals underwent micro-CT and a series of micro-PET scans. 21 days after they were sacrificed to measure lung mechanics and collagen deposition. Results: Histological analysis showed a rapid recruitment of neutrophils into the damaged lung 6 hours after injury, with a peak after 24 hours. Macrophages, as expected, reached the peak after 48 hours. [18F]FDG signal, as inflammation marker, showed similar time course to that of recruited inflammatory cells (sum of two cell types). Mice that were sacrificed 21 days after the surgery were characterized by a correlation between a reduced respiratory static compliance and a high PET signal 7 days after lung injury. PET signal correlated also with collagen content. This correlation was confirmed in treatment experiment, in which we found that exogenous surfactant administration improved lung fibrotic evolution, by reducing collagen deposition. Conclusions: This study demonstrated the possibility to use PET imaging to follow the inflammatory response also in longitudinal studies. Moreover a correlation between a persistence of inflammatory process and fibrotic evolution was showed. We speculate that it is possible that acute treatments of the inflammation capable of reducing the fibroproliferative process, could be monitored using the FDG-PET method.
APA, Harvard, Vancouver, ISO, and other styles
2

Forsythe, Rachael Olivia. "Assessment of abdominal aortic aneurysm biology using magnetic resonance imaging and positron emission tomography-computed tomography." Thesis, University of Edinburgh, 2018. http://hdl.handle.net/1842/29619.

Full text
Abstract:
Background Although abdominal aortic aneurysm (AAA) growth is non-linear, serial measurements of aneurysm diameter are the mainstay of aneurysm surveillance and contribute to decisions on timing of intervention. Aneurysm biology plays a key part in disease evolution but is not currently routinely assessed in clinical practice. Magnetic Resonance Imaging (MRI) and Positron Emission Tomography-Computed Tomography (PET-CT) provide insight into disease processes on a cellular or molecular level, and represent exciting new imaging biomarkers of disease activity. Macrophage-mediated inflammation may be assessed using ultrasmall superparamagnetic particles of iron oxide (USPIO) MRI and the PET radiotracer 18FSodium Fluoride (18F-NaF) identifies microcalcification which is a response to underlying necrotic inflammation. The central aim of this thesis was to investigate these imaging modalities in patients with AAA. Methods and Results USPIO MRI: MULTI-CENTRE STUDY In a prospective multi-centre observational cohort study, 342 patients (85.4% male, mean age 73.1±7.2 years, mean AAA diameter 49.6±7.7mm) with asymptomatic AAA ≥4 cm anteroposterior diameter underwent MRI before and 24-36 hours after intravenous administration of USPIO. Colour maps (depicting the change in T2* caused by USPIO) were used to classify aneurysms on the basis of the presence of USPIO uptake in the aneurysm wall, representing mural inflammation. Intra- and inter-observer agreement were found to be very good, with proportional agreement of 0.91 (kappa 0.82) and 0.83 (kappa 0.66), respectively. At 1 year, there was 29.3% discordant classification of aneurysms on repeated USPIO MRI and at 2 years, discordance was 65%, suggesting that inflammation evolves over time. In the observational study, after a mean of 1005±280 days of follow up, there were 126 (36.8%) aneurysm repairs and 17 (5.0%) ruptures. Participants with USPIO enhancement (42.7%) had increased aneurysm expansion rates (3·1±2·5 versus 2·5±2·4 mm/year; difference 0·6 [95% confidence intervals (CI), 0·02 to 1·2] mm/year, p=0·0424) and had higher rates of aneurysm rupture or repair (69/146=47·3% versus 68/191=35·6%; difference 11·7%, 95% CI 1·1 to 22·2%, p=0·0308). USPIO MRI was therefore shown to predict AAA expansion and the composite of rupture or repair, however this was not independent of aneurysm diameter (c-statistic, 0·7924 to 0·7926; unconditional net reclassification -13·5%, 95% confidence intervals -36·4% to 9·3%). 18F-NaF PET-CT: SINGLE-CENTRE STUDY A sub-group of 76 patients also underwent 18F-NaF PET-CT, which was evaluated using the maximum tissue-to-background ratio (TBRmax) in the most diseased segment (MDS), a technique that showed very good intra- (ICC 0.70-0.89) and inter-observer (ICC 0.637-0.856) agreement. Aneurysm tracer uptake was compared firstly in a case-control study, with 20 patients matched to 20 control patients for age, sex and smoking status. 18F-NaF uptake was higher in aneurysm when compared to control aorta (log2TBRmax 1.712±0.560 vs. 1.314±0.489; difference 0.398 (95% CI 0.057, 0.739), p=0.023), or to non-aneurysmal aorta in patients with AAA (log2TBRmax 1.647±0.537 vs. 1.332±0.497; difference 0.314 (95% CI 0.0685, 0.560), p=0.004). An ex vivo study was performed on aneurysm and control tissue, which demonstrated that 18F-NaF uptake on microPET-CT was higher in the aneurysm hotspots and higher in aneurysm tissue compared to control tissue. Histological analysis suggested that 18F-NaF was highest in areas of focal calcification and necrosis. In an observational cohort study, aneurysms were stratified by tertiles of TBRmax in the MDS and followed up for 510±196 days, with 6 monthly serial ultrasound measurements of diameter. Those in the highest tertile of tracer uptake expanded more than 2.5 times more rapidly than those in the lowest tertile (3.10 [3.58] mm/year vs. 1.24 [2.41] mm/year, p=0.008) and were also more likely to experience repair or rupture (15.3% vs. 5.6%, log-rank p=0.043). In multivariable analyses, 18F-NaF uptake on PET-CT emerged as an independent predictor of AAA expansion (p=0.042) and rupture or repair (HR 2.49, 95% CI1.07, 5.78; p=0.034), even when adjusted for age, sex, body mass index, systolic blood pressure, current smoking and, crucially, aneurysm diameter. Conclusion These are the largest USPIO MRI and PET-CT studies in AAA disease to date and the first to investigate 18F-NaF. Both USPIO MRI and 18F-NaF PET-CT are able to predict AAA expansion and the composite of rupture and repair, with 18F-NaF PETCT emerging as the first imaging biomarker that independently predicts expansion and AAA events, even after adjustment for aneurysm diameter. This represents an exciting new predictor of disease progression that adds incremental value to standard clinical assessments. Feasibility and randomised clinical trials are now required to assess the potential of this technique to change the management and outcome of patients with AAA.
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "ARDS, PET imaging, CT imaging, inflammation"

1

Zaret, Barry L. Nuclear Cardiology. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199392094.003.0001.

Full text
Abstract:
Nuclear cardiology is generally considered a clinical phenomenon of the past four decades. However, the field has its roots in earlier times. This chapter focuses on these historical roots as they have evolved into the present era. The initial application of radioisotopes to cardiac studies occurred in the mid-1920s. Ventricular function was evaluated in the 1960s and 1970s by first pass and equilibrium techniques. Myocardial stress perfusion imaging was first performed using potassium-43 and exercise in 1973. Stress imaging rapidly evolved thereafter with new tracers (thallium-201 and technetium-labeled agents) and from planar to SPECT approaches. Perfusion imaging rapidly proved its value diagnostically and in assessing prognosis. Infarct imaging reached its peak use in the 1970s but is now no longer employed. Advances in hybrid imaging, combining CT with radionuclide imaging has recently allowed attenuation correction as well as providing the combination of anatomic and physiologic data. PET myocardial perfusion studies have recently become a standard approach for evaluating perfusion, absolute coronary blood flow and coronary reserve. PET FDG studies of cardiac sarcoidosis have recently been established as a new approach for defining myocardial inflammation. New SPECT systems provide high sensitivity, high resolution studies, allowing for radiation dose reduction and high quality imaging studies.
APA, Harvard, Vancouver, ISO, and other styles
2

Al-Nahhas, Adil, and Imene Zerizer. Nuclear medicine. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0070.

Full text
Abstract:
The application of nuclear medicine techniques in the diagnosis and management of rheumatological conditions relies on its ability to detect physiological and pathological changes in vivo, usually at an earlier stage compared to structural changes visualized on conventional imaging. These techniques are based on the in-vivo administration of a gamma-emitting radionuclide whose distribution can be monitored externally using a gamma camera. To guide a radionuclide to the area of interest, it is usually bound to a chemical label to form a 'radiopharmaceutical'. There are hundreds of radiopharmaceuticals in clinical use with different 'homing' mechanisms, such as 99 mTc HDP for bone scan and 99 mTc MAA for lung scan. Comparing pre- and posttherapy scans can aid in monitoring response to treatment. More recently, positron emission tomography combined with simultaneous computed tomography (PET/CT) has been introduced into clinical practice. This technique provides superb spatial resolution and anatomical localization compared to gamma-camera imaging. The most widely used PET radiopharmaceutical, flurodeoxyglucose (18F-FDG), is a fluorinated glucose analogue, which can detect hypermetabolism and has therefore been used in imaging and monitoring response to treatment of a variety of cancers as well as inflammatory conditions such as vasculitis, myopathy, and arthritides. Other PET radiopharmaceuticals targeting inflammation and activated macrophages are becoming available and could open new frontiers in PET imaging in rheumatology. Nuclear medicine procedures can also be used therapeutically. Beta-emitting radiopharmaceuticals, such as yttrium-90, invoke localized tissue damage at the site of injection and can be used in the treatment of synovitis.
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "ARDS, PET imaging, CT imaging, inflammation"

1

Emami, Hamed, and Ahmed Tawakol. "PET/CT Imaging of Inflammation and Calcification." In Cardiovascular Imaging, 327–53. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-09268-3_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Shaikh, Sikandar. "Dual Time Point PET-CT Imaging." In PET-CT in Infection and Inflammation, 39–57. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-9801-2_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Shaikh, Sikandar. "Molecular Imaging in Infection and Inflammation." In PET-CT in Infection and Inflammation, 281–91. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-9801-2_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Vesey, Alex Thomas, Marc Richard Dweck, and David Ernest Newby. "PET/CT Imaging of Inflammation and Calcification in CAVD: Clinical Studies." In Cardiovascular Imaging, 201–23. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-09268-3_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Amorim, Barbara Juarez, Benedikt Michael Schaarschmidt, Johannes Grueneisen, Shahein Tajmir, Lale Umutlu, Alberto Signore, and Onofrio Antonio Catalano. "Nuclear Medicine Imaging of Infection/Inflammation by PET/CT and PET/MR." In Nuclear Medicine in Infectious Diseases, 213–35. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-25494-0_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Di Carli, Marcelo F., Raffaele Giubbini, D. Albano, E. Milan, I. Carvajal, E. Alexanderson, Diana Paez, and Maurizio Dondi. "Technical Considerations for Cardiac PET/CT." In IAEA Atlas of Cardiac PET/CT, 1–24. Berlin, Heidelberg: Springer Berlin Heidelberg, 2022. http://dx.doi.org/10.1007/978-3-662-64499-7_1.

Full text
Abstract:
AbstractPositron emission tomography (PET) is a non-invasive imaging technique that employs positron-emitting radionuclides labelled to biological molecules. Unlike other imaging techniques, such as computer tomography (CT) and magnetic resonance imaging (MRI) that provide anatomical or structural information, PET allows obtaining unique quantitative information of important biologic processes in vivo (e.g. myocardial perfusion and metabolism, inflammation, innervation, receptor density).
APA, Harvard, Vancouver, ISO, and other styles
7

Di Carli, Marcelo F., Raffaele Giubbini, M. Williams, M. Bertoli, Maurizio Dondi, Diana Paez, and E. Milan. "Emerging Applications." In IAEA Atlas of Cardiac PET/CT, 197–207. Berlin, Heidelberg: Springer Berlin Heidelberg, 2022. http://dx.doi.org/10.1007/978-3-662-64499-7_5.

Full text
Abstract:
AbstractCardiovascular imaging has recently expanded to the search for unstable plaques at high risk of rupturing and causing acute coronary events. A vulnerable plaque has been described histologically as a plaque with a large lipid core, a thin fibrous cap, and inflammation at the margins of the plaque. One of the most interesting recent findings is the discovery that plaques exhibiting high-risk characteristics may be associated with inducible myocardial ischemia even in the absence of luminal obstruction. Currently, anatomical and functional imaging of coronary atherosclerosis can be performed with computed tomography angiography and positron emission tomography, as briefly reviewed in this chapter.
APA, Harvard, Vancouver, ISO, and other styles
8

Di Carli, Marcelo F., Raffaele Giubbini, M. Williams, M. Bertoli, Maurizio Dondi, Diana Paez, and E. Milan. "Emerging Applications." In IAEA Atlas of Cardiac PET/CT, 197–207. Berlin, Heidelberg: Springer Berlin Heidelberg, 2022. http://dx.doi.org/10.1007/978-3-662-64499-7_5.

Full text
Abstract:
AbstractCardiovascular imaging has recently expanded to the search for unstable plaques at high risk of rupturing and causing acute coronary events. A vulnerable plaque has been described histologically as a plaque with a large lipid core, a thin fibrous cap, and inflammation at the margins of the plaque. One of the most interesting recent findings is the discovery that plaques exhibiting high-risk characteristics may be associated with inducible myocardial ischemia even in the absence of luminal obstruction. Currently, anatomical and functional imaging of coronary atherosclerosis can be performed with computed tomography angiography and positron emission tomography, as briefly reviewed in this chapter.
APA, Harvard, Vancouver, ISO, and other styles
9

Mahrholdt, Heiko, Ali Yilmaz, and Udo Sechtem. "Myocarditis." In The ESC Textbook of Cardiovascular Imaging, 536–48. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780198703341.003.0039.

Full text
Abstract:
The symptoms and signs of myocarditis are non-specific. Thus, myocarditis is a differential diagnosis in many patients with heart complaints. As clinical tools, such as history taking, physical examination, blood tests, the ECG, and the chest X-ray are not sufficient to ascertain the diagnosis of myocarditis, additional information from cardiac imaging techniques, or endomyocardial biopsy are necessary to confirm or exclude the disease. Echocardiography still represents the first-choice imaging modality in patients with a clinical suspicion of myocarditis, since it offers the acquisition of comprehensive anatomic and functional data very quickly at the bedside of the patient. Due to its non-invasiveness, the lack of radiation exposure, its image quality, which helps assessing and quantifying cardiac function, and its high tissue contrast, which can be modified using various pulse sequences, CMR has become an important technique for evaluating patients with suspected myocarditis. Emerging hybrid PET/CT and PET/MRI techniques may have considerable potential for future cardiovascular inflammation imaging because they combine PET, a highly sensitive and quantitative modality to detect even low-grade inflammation, with CT or MRI that enable non-invasive assessment of cardiovascular anatomy with excellent spatial resolution. However, when managing patients with inflammatory heart disease today, it should be kept in mind that endomyocardial biopsy remains the only technique that can directly assess the presence and intensity of myocardial inflammation in vivo. Therefore, it is the technique of choice if clinically indicated to differentiate between active and healed myocarditis.
APA, Harvard, Vancouver, ISO, and other styles
10

Mulders-Manders, Catharina M., Ilse J. E. Kouijzer, and Lioe-Fee de Geus-Oei. "18F-FDG-PET/CT imaging in fever and inflammation of unknown origin." In Reference Module in Biomedical Sciences. Elsevier, 2021. http://dx.doi.org/10.1016/b978-0-12-822960-6.00035-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "ARDS, PET imaging, CT imaging, inflammation"

1

Kassai, Miklos, Andre Dos Santos Rocha, Gergely Fodor, Roberta Sudy, Loïc Degrugilliers, Ferenc Petak, Walid Habre, and Sam Bayat. "Regional distribution of lung inflammation in a multiple-hit model of ARDS assessed by micro-PET-CT imaging in juvenile rabbits." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa3166.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hagan, Guy, James H. F. Rudd, Carmen M. Treacy, Kathy Page, Robert V. MacKenzie Ross, Nicholas Screaton, Nick Bird, Nicholas W. Morrell, Mark Southwood, and Joanna Pepke-Zaba. "Imaging Of Vascular Inflammation In Pulmonary Hypertension - An 18FDG PET/CT Study." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a2005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Auslander, Thomas M., Sofia Miguez, Alexandra Batzdorf, Olivia Sorci, Marie Lim, Brandon C. Jones, Michael Mayer, Poul F. Høilund-Carlsen, Abass Alavi, and Chamith S. Rajapakse. "Using FDG and NaF PET/CT imaging to investigate the relationship between inflammation and microcalcification in the aorta." In Biomedical Applications in Molecular, Structural, and Functional Imaging, edited by Barjor Gimi and Andrzej Krol. SPIE, 2019. http://dx.doi.org/10.1117/12.2512744.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Douhi, Abdelillah, Mamdouh S. Al-Enezi, Abdelouahed Khalil, Tamas Fulop, Eric Turcotte, Michel Nguyen, and M'hamed Bentourkia. "Coupling of 18F-NaF and 18F-FDG PET/CT Dynamic Imaging for the Detection of Arterial Inflammation." In 2021 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC). IEEE, 2021. http://dx.doi.org/10.1109/nss/mic44867.2021.9875576.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Fiz, F., A. Nieri, S. Morbelli, A. Piccardo, M. Riondato, A. Ciarmiello, GM Sambuceti, and C. la Fougère. "Role of somatostatin receptor and FDG imaging in capturing plaque inflammation: a PET/CT analysis, corroborated by clinical data." In NuklearMedizin 2019. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1683537.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hayer, Silvia, Markus Zeilinger, Volker Weiss, Markus Seibt, Birgit Niederreiter, Tetyana Shvets, Monika Dumanic, et al. "04.15 Resolution of systemic inflammatory processes and regeneration of inflammation-driven bone damage upon tnf blockade as monitored by in vivo multimodal pet-ct imaging in tnf driven experimental arthritis." In 37th European Workshop for Rheumatology Research 2–4 March 2017 Athens, Greece. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2016-211051.15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Slart, R. "FRI0589 A joint procedural recommendation on fdg-pet/ct(A) imaging in large vessel vasculitis and polymyalgia rheumatica from the cardiovascular and inflammation & infection committees of the eanm, the cardiovascular council of the snmmi, the pet interest group (PIG), and endorsed by the asnc." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.1181.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'ARDS, PET imaging, CT imaging, inflammation' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography